New scan could spot hidden cancers better than current methods
NCT ID NCT06503146
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new imaging agent called [18F]FAPI-74 can find certain cancers as well as or better than the standard PET tracer. About 320 adults with one of 11 cancer types (including pancreatic, liver, ovarian, and lung cancers) will receive both tracers and have their scans compared. The goal is to see if the new tracer detects more tumors, which could improve cancer diagnosis and treatment planning.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new protein drug shield kids with cancer from dangerous infections?
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?
- Can a cancer vaccine prime the body to better fight liver tumors?
- Can a Three-Drug cocktail shrink stomach tumors before surgery?
- Can removing bladder tumors in one piece improve cancer outcomes?